(HealthDay News) — An experimental hormone therapy pill has shown promise in extending the lives of women with tough-to-treat advanced breast cancer, a new clinical trial shows. The drug, imlunestrant, improved progression-free survival in patients whose breast cancer was driven by read more about A Clinical Trial Extended the Life of Women With Hard-to-Treat Breast Cancer
Black Americans have historically been misrepresented in the medical industry, often subjected to unequal treatment and exclusion from medical advancements. This disparity is why it’s important for medical professionals, researchers, policymakers and advocates like Tony Newberne are important because these read more about Why This Multiple Myeloma Survivor Advocates for Clinical Trials
(HealthDay News) — There's new hope for people battling advanced bladder cancer who do not respond to first-line therapy, researchers report. An experimental new drug with the unwieldy name of cretostimogene grenadenorepvec spurred complete remission of the cancer in three-quarters read more about A New Hope for Hard-to-Treat Bladder Cancer Made It Through Clinical Trials
Black adults face disparities in both diagnosing and treating Parkinson’s disease. Parkinson’s disease (PD) is a chronic, progressive neurological disorder that can cause stiffness, slowed movement, and tremors, typically for older adults in their 60s. Age, gender, environmental exposure, and read more about Oschner Health Is Taking on First-of-Its-Kind Black Parkinson’s Research
(HealthDay News) — Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical trial funded by Lilly. "Given the increased interest around obesity medications, we conducted this study to help read more about Zepbound Outperforms Wegovy in Weight Loss Clinical Trial
